An evaluation of community methadone services in Victoria, Australia: results of a client survey
An evaluation of community methadone services in Victoria, Australia: results of a client survey
复制标题
DOI：
10.1080/09595239996284
复制
发表时间：
1999-12-01
影响因子：
3.8
通讯作者：
Lanagan, A
中科院分区：
文献类型：
--
作者：
Ezard, N;Lintzeris, N;Lanagan, A
195名参加澳大利亚维多利亚州社区美沙酮计划的大都市客户接受了调查，以评估客户对初级卫生保健机构提供的美沙酮治疗的看法。结果表明，美沙酮的日平均剂量为41毫克，范围为7-140毫克。大部分顾客对这项计划及由药房配药和医生处方所提供的服务感到满意。自开始使用美沙酮以来，大多数吸毒者被发现减少了海洛因的使用和犯罪活动。然而，对该方案提出了一些关切，包括每周收入用于与美沙酮有关的活动的比例很高，以及客户在服用较高剂量的美沙酮时大量使用镇静剂。总的来说，以社区为基础的美沙酮计划被发现是向澳大利亚维多利亚州的大都市客户提供服务的一种可接受的美沙酮。
One hundred and ninety-five metropolitan clients enrolled in the community-based methadone programme in Victoria, Australia were surveyed in order to evaluate client perspectives of methadone treatment delivered from primary health care settings. Results indicated that the average daily methadone dose was 41 mg, ranging from 7 mg to 140 mg. The majority of clients were satisfied with the programme and the services delivered by dispensing pharmacies and prescribing doctors. Most clients were found to have reduced their heroin use and criminal activity since commencing methadone. A number of concerns about the programme were identified, however, including the high proportion of weekly income spent on methadone-related activities and a high use of tranquillizers by clients on higher methadone doses. In general the community-based methadone programme was found to be an acceptable methadone of service delivery to metropolitan clients in Victoria, Australia.